CINA-iPE
Avicenna.AI
| Product specifications |
Information source:
Vendor
Last updated: March 10, 2023 |
| General | |
|---|---|
| Product name | CINA-iPE |
| Company | Avicenna.AI |
| Subspeciality | Chest |
| Modality | CT |
| Disease targeted | Pulmonary embolism |
| Key-features | Pulmonary embolism detection, notification |
| Suggested use | Before: adapting worklist order, flagging acute findings |
| Data characteristics | |
| Population | Patient with CTA scan ordered for indications other than suspected PE |
| Input | Chest and thoraco-abdominal CT angiographies (CTA) |
| Input format | DICOM |
| Output | bounding box, worklist order, notification |
| Output format | DICOM SC, GSPS |
| Technology | |
| Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform |
| Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based |
| Trigger for analysis | Automatically, right after the image acquisition |
| Processing time | 10 - 60 seconds |
| Certification | |
|
CE
|
Certified,
Class I
, MDD
|
|
FDA
|
No or not yet |
| Market presence | |
| On market since | 02-2023 |
| Distribution channels | Eureka Clinical AI |
| Countries present (clinical, non-research use) | |
| Paying clinical customers (institutes) | |
| Research/test users (institutes) | |
| Pricing | |
| Pricing model | Pay-per-use, Subscription |
| Based on | Number of installations, Number of analyses |
| Evidence | |
| Peer reviewed papers on performance | |
| Non-peer reviewed papers on performance | |
| Other relevant papers | |